Age Related Cataracts

Ophthalmology·MeSH: Cataract

5 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
control	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

Phase 2(3)

Drug	Company
0.4% zoc2017217	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
0.4% zoc2017217	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
0.4% ZOC2017217	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 4(1)

Drug	Company
Control	Crinetics Pharmaceuticals, Inc. (CRNX)

BioSniper tracks 5 drugs in development for Age Related Cataracts across 3 companies.

There are 1 clinical trial targeting Age Related Cataracts tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.